Building stakeholder confidence in biosimilar medicines through evidence-based information sharing

Category: Special Report
Author(s):
Visits: 50 total, 1 today
The European Commission held a stakeholder event to discuss biosimilar medicinal products in May 2017. A session on building stakeholder confidence in biosimilar medicines provided an update of the latest available clinical experiences with biosimilar medicines, focusing on switching between biological medicines and interchangeability. Assistant Professor Gianluca Trifirò from the University of Messina, Italy, discussed these issues from the perspective of physicians in Italy.

Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.

Go Back Print

Leave a Reply